Showing results (1741-1750 of 1,908) with videos related to

Sort By:
Pageof 191
Risk Management and Healthcare Policy|March 3, 2026
An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital SettingAlessandro Morabito, Piera Maiolino, Stefania D'Auria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trialKomal Jhaveri, Hope S Rugo, Javier Cortés, et al.
Gastrointestinal Endoscopy|November 22, 2023
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international studyMarietta Iacucci, Stefanos Bonovas, Alina Bazarova, et al.
Endoscopy|August 1, 2022
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement InitiativeEvelien Dekker, Karlijn J Nass, Marietta Iacucci, et al.
Journal of Clinical Medicine|October 27, 2019
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerHariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, et al.
Epidemiology and Infection|December 24, 2008
A comparison of hepatitis B seroepidemiology in ten European countriesA Nardone, C G Anastassopoulou, H Theeten, et al.
Epidemiology and Infection|February 24, 2005
The seroepidemiology of Bordetella pertussis infection in Western EuropeR G Pebody, N J Gay, A Giammanco, et al.
BMJ Global Health|August 23, 2022
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021Hannah C Lewis, Harriet Ware, Mairead Whelan, et al.
Hypertension (Dallas, Tex. : 1979)|December 5, 2025
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.
Frontiers in Oncology|December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Pageof 191